Adial Pharmaceuticals Inc

Other US ADIWW

NoneUSD
-(-%)

Last update at 2024-03-07T21:02:32.284370Z

Day Range

--
LowHigh

52 Week Range

0.00020.01
LowHigh

Fundamentals

  • Previous Close 0.0048
  • Market Cap0.00000M
  • VolumeNone
  • P/E Ratio-
  • Dividend Yield-%
  • Revenue TTM0.00000M
  • Revenue Per Share TTM-
  • Gross Profit TTM 0.00000M
  • Diluted EPS TTM-

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Financials

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2020-12-31 2019-12-31
Type yearly yearly
Date 2020-12-31 2019-12-31
Income before tax -10.89299M -8.59143M
Minority interest - -
Net income -10.89299M -8.59143M
Selling general administrative 5.07M 4.28M
Selling and marketing expenses - -
Gross profit - -
Reconciled depreciation - -
Ebit -10.92798M -8.59143M
Ebitda -10.89299M -
Depreciation and amortization 0.03M -
Non operating income net other 0.03M -0.34653M
Operating income -10.92798M -8.24490M
Other operating expenses 10.93M -
Interest expense 0.00000M 0.00000M
Tax provision - -
Interest income - -
Net interest income - -
Extraordinary items - -
Non recurring - -
Other items - -
Income tax expense - -
Total revenue - -
Total operating expenses 10.93M 8.24M
Cost of revenue - -
Total other income expense net 0.03M -
Discontinued operations - -
Net income from continuing ops -10.89299M -8.59143M
Net income applicable to common shares -10.89299M -8.59143M
Preferred stock and other adjustments - -
Breakdown 2020-12-31 2019-12-31
Type yearly yearly
Date 2020-12-31 2019-12-31
Total assets 5.49M 7.68M
Intangible assets 0.00561M -
Earning assets - -
Other current assets 0.73M 0.90M
Total liab 1.51M 0.54M
Total stockholder equity 3.99M 7.14M
Deferred long term liab - -
Other current liab 0.86M -
Common stock 0.01M 0.01M
Capital stock - -
Retained earnings -31.51979M -20.62680M
Other liab - -
Good will - -
Other assets - -
Cash 4.40M 6.78M
Cash and equivalents - -
Total current liabilities 1.51M 0.54M
Current deferred revenue - -
Net debt -4.40111M -
Short term debt - -
Short long term debt - -
Short long term debt total - -
Other stockholder equity 3.97M -
Property plant equipment - -
Total current assets 5.14M 7.67M
Long term investments - -
Net tangible assets 3.98M 7.14M
Short term investments - -
Net receivables - -
Long term debt - -
Inventory - -
Accounts payable 0.65M 0.54M
Total permanent equity - -
Noncontrolling interest in consolidated entity - -
Temporary equity redeemable noncontrolling interests - -
Accumulated other comprehensive income - -
Additional paid in capital - -
Common stock total equity 0.01M 0.01M
Preferred stock total equity - -
Retained earnings total equity -31.51979M -20.62680M
Treasury stock - -
Accumulated amortization - -
Non currrent assets other 0.35M 0.00617M
Deferred long term asset charges - -
Non current assets total 0.36M 0.00617M
Capital lease obligations - -
Long term debt total - -
Breakdown 2020-12-31 2019-12-31
Type yearly yearly
Date 2020-12-31 2019-12-31
Investments -0.35000M -
Change to liabilities 1.08M 0.28M
Total cashflows from investing activities -0.35000M -
Net borrowings - -
Total cash from financing activities 5.61M 9.25M
Change to operating activities - -
Net income -10.89299M -8.59143M
Change in cash -2.37594M 2.91M
Begin period cash flow - -
End period cash flow - -
Total cash from operating activities -7.63316M -6.33861M
Issuance of capital stock - -
Depreciation 0.00056M 0.00056M
Other cashflows from investing activities - -
Dividends paid - -
Change to inventory - -
Change to account receivables - -
Sale purchase of stock 5.61M 9.25M
Other cashflows from financing activities - -
Change to netincome 2.01M 1.60M
Capital expenditures 0.00000M 0.00000M
Change receivables - -
Cash flows other operating 0.16M 0.37M
Exchange rate changes - -
Cash and cash equivalents changes -2.37594M 2.91M
Change in working capital - -
Stock based compensation - -
Other non cash items - -
Free cash flow - -

Peer Comparison

Sector: Other Industry: Other

Company Change (USD) Price (USD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x)
ADIWW
Adial Pharmaceuticals Inc
- -% - - - - -
FREJO
Federal Home Loan Mortgage Corporation PFD 5.1% SAL
3.64 23.95% 18.84 - - - -
SFB
Stifel Financial Corporation 5.20% Senior Notes due 2047
-0.04 0.20% 20.00 - - - -
JSM
Navient Corporation SR NT 6% 121543
-0.31 1.69% 18.01 15.90 - - -
BHFAL
Brighthouse Financial Inc
-0.1006 0.50% 19.90 - - - -

Reports Covered

Stock Research & News

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.